Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model

Stem Cell Research and Therapy

Volumn 2, Issue 1, 2011, Pages

  Watts, Ashlee E ^a   Yeager, Amy E ^a   Kopyov, Oleg V ^b   Nixon, Alan J ^a  

^a Department of Molecular Biology and Genetics   (United States)

^b Celavie Biosciences LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; COLLAGEN; GLYCOSAMINOGLYCAN; OCTAMER TRANSCRIPTION FACTOR 4; PHENYLBUTAZONE; PROTEOGLYCAN; STAGE SPECIFIC EMBRYO ANTIGEN 4; TELOMERASE; TRANSCRIPTION FACTOR NANOG; DNA; TESTIS DETERMINING FACTOR;

18S GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL LAMENESS; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; CELL SURVIVAL; COL1A1 GENE; COL3A1 GENE; COMP GENE; CONTROLLED STUDY; DCN GENE; ECHOGRAPHY; EMBRYO; EMBRYONIC STEM CELL; FEMALE; FETUS; FLEXOR TENDON INJURY; GENE; GENE EXPRESSION; HISTOPATHOLOGY; HORSE; HUMAN; HUMAN CELL; MALE; MMP1 GENE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCX GENE; SRY GENE; TENDINITIS; TNC GENE; TNMD GENE; TREATMENT DURATION; WOUND HEALING; ANIMAL; ANIMAL DISEASE; CYTOLOGY; DISEASE MODEL; GENETICS; HORSE DISEASE; IMMUNOLOGY; METABOLISM; PATHOLOGY; REGENERATIVE MEDICINE; STEM CELL; STEM CELL TRANSPLANTATION; TENDON INJURY;

ANIMALIA; EQUIDAE;

ANIMALS; COLLAGEN; DISEASE MODELS, ANIMAL; DNA; FEMALE; HORSE DISEASES; HORSES; MAGNETIC RESONANCE IMAGING; MALE; PROTEOGLYCANS; REGENERATIVE MEDICINE; SEX-DETERMINING REGION Y PROTEIN; STEM CELL TRANSPLANTATION; STEM CELLS; TENDON INJURIES; WOUND HEALING;

EID: 79961238019     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt45     Document Type: Article

References (54)

1. Biology of tendon injury: healing, modeling and remodeling. Sharma P Maffulli N, J Musculoskelet Neuronal Interact 2006 6 181 90 16849830 (Pubitemid 44193219)
2. Achilles tendinopathy: some aspects of basic science and clinical management. Kader D Saxena A, Movin T Maffulli N, Br J Sports Med 2002 36 239 249 10.1136/bjsm.36.4.239 12145112 (Pubitemid 34833115)
3. An assessment of wastage in thoroughbred racing from conception to 4 years of age. Jeffcott LB Rossdale PD Freestone J Frank CJ, Towers-Clark PF, Equine Vet J 1982 14 185 198 10.1111/j.2042-3306.1982.tb02389.x 7106081
4. Epidemiological study of wastage among racehorses 1982 and 1983. Rossdale PD Hopes R, Digby NJ Offord K, Vet Rec 1985 116 66 69 10.1136/vr.116.3.66 3976145
5. Pathogenesis of tendinopathies: inflammation or degeneration? Abate M Gravare Silbernagel K, Siljeholm C Di Iorio A, De Amicis D Salini V, Werner S Paganelli R, Arthritis Res Ther 2009 11 235 10.1186/ar2723 19591655
6. Superficial digital flexor tendonitis in the horse. Dowling BA Dart AJ, Hodgson DR Smith RK, Equine Vet J 2000 32 369 378 10.2746/042516400777591138 11037257
7. Tendon injury and tendinopathy: healing and repair. Sharma P Maffulli N, J Bone Joint Surg Am 2005 87 187 202 10.2106/JBJS.D.01850 15634833 (Pubitemid 40094160)
8. Interventions for treating acute and chronic Achilles tendinitis. Mclauchlan GJ Handoll HH, Cochrane Database Syst Rev 2001 d000232 11405956
9. Current treatment options for tendinopathy. Maffulli N Longo Ug, Loppini M Denaro V, Expert Opin Pharmacother 2010 11 2177 2186 10.1517/14656566.2010. 495715 20569088
10. The early surface cell response to flexor tendon injury. Jones ME Mudera V, Brown RA Cambrey AD, Grobbelaar AO McGrouther DA, J Hand Surg Am 2003 28 221 230 10.1053/jhsu.2003.50044 12671852 (Pubitemid 36373317)
11. Chondrogenic and adipogenic potential of microvascular pericytes. Farrington-Rock C Crofts NJ, Doherty MJ Ashton BA, Griffin-Jones C Canfield AE, Circulation 2004 110 2226 2232 10.1161/01.CIR.0000144457.55518.E5 15466630 (Pubitemid 39372506)
12. Cell phenotypic variation in normal and damaged tendons. Clegg PD Strassburg S Smith RK, Int J Exp Pathol 2007 88 227 235 10.1111/j.1365-2613. 2007.00549.x 17696903 (Pubitemid 47256310)
13. Tissue engineering of ligament and tendon healing. Woo SL Hildebrand K, Watanabe N Fenwick JA, Papageorgiou CD Wang JH, Clin Orthop Relat Res 1999 312 323 10.1097/00003086-199910001-00030 10546655
14. Application of bone marrow-derived mesenchymal stem cells in a rotator cuff repair model. Gulotta LV Kovacevic D, Ehteshami JR Dagher E, Packer JD Rodeo SA, Am J Sports Med 2009 37 2126 2133 10.1177/0363546509339582 19684297
15. Synovial mesenchymal stem cells accelerate early remodeling of tendon-bone healing. Ju YJ Muneta T Yoshimura H Koga H, Sekiya I, Cell Tissue Res 2008 332 469 478 10.1007/s00441-008-0610-z 18418628
16. Bone marrow-derived mesenchymal stem cells influence early tendon-healing in a rabbit achilles tendon model. Chong AK Ang AD Goh JC Hui JH, Lim AY Lee EH, Lim BH, J Bone Joint Surg Am 2007 89 74 81 10.2106/JBJS.E.01396 17200313 (Pubitemid 46061406)
17. Mesenchymal stem cells and insulin-like growth factor-i gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. Schnabel LV Lynch ME, van der Meulen MC Yeager AE, Kornatowski MA Nixon AJ, J Orthop Res 2009 27 1392 1398 10.1002/jor.20887 19350658
18. Cell therapy for tendinitis, experimental and clinical report. Lacitignola L Crovace A, Rossi G Francioso E, Vet Res Commun 2008 32 33 38 10.1007/s11259-008-9085-3 18686004
19. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. Nixon AJ Dahlgren LA Haupt JL Yeager AE, Ward DL, Am J Vet Res 2008 69 928 937 10.2460/ajvr.69.7.928 18593247
20. Histology and immunohistochemistry study of ovine tendon grafted with cbmscs and bmmncs after collagenase-induced tendinitis. Crovace A Lacitignola L, Francioso E Rossi G, Vet Comp Orthop Traumatol 2008 21 329 336 18704239
21. Mesenchymal stem cell therapy for equine tendinopathy. Smith RK, Disabil Rehabil 2008 30 1752 1758 10.1080/09638280701788241 18608378
22. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Smith RK Korda M, Blunn GW Goodship AE, Equine Vet J 2003 35 99 102 10.2746/042516403775467388 12553472 (Pubitemid 39663047)
23. Regenerative versus reparative healing in tendon: a study of biomechanical and histological properties in fetal sheep. Beredjiklian PK Favata M, Cartmell JS Flanagan CL, Crombleholme TM Soslowsky LJ, Ann Biomed Eng 2003 31 1143 1152 10.1114/1.1616931 14649488
24. Stepwise differentiation of human embryonic stem cells promotes tendon regeneration by secreting fetal tendon matrix and differentiation factors. Chen X Song XH Yin Z Zou XH, Wang LL Hu H, Cao T Zheng M, Ouyang HW, Stem Cells 2009 27 1276 1287 10.1002/stem.61 19489094
25. The pursuit of es cell lines of domesticated ungulates. Talbot NC Blomberg Le A, Stem Cell Rev 2008 4 235 254 10.1007/s12015-008-9026-0 18612851
26. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Takahashi K Yamanaka S, Cell 2006 126 663 676 10.1016/j.cell.2006.07.024 16904174 (Pubitemid 44233629)
27. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K Tanabe K Ohnuki M Narita M, Ichisaka T Tomoda K, Yamanaka S, Cell 2007 131 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
28. Induced pluripotent stem cell lines derived from human somatic cells. Yu J Vodyanik MA, Smuga-Otto K Antosiewicz-Bourget J, Frane JL Tian S, Nie J Jonsdottir GA, Ruotti V Stewart R, Slukvin II Thomson JA, Science 2007 318 1917 1920 10.1126/science.1151526 18029452
29. Generation of germline-competent induced pluripotent stem cells. Okita K Ichisaka T Yamanaka S, Nature 2007 448 313 317 10.1038/nature05934 17554338 (Pubitemid 47080336)
30. Expression of insulin-like growth factor binding proteins in healing tendon lesions. Dahlgren LA Mohammed HO Nixon AJ, J Orthop Res 2006 24 183 192 10.1002/jor.20000 16435347 (Pubitemid 43773029)
31. Temporal expression of growth factors and matrix molecules in healing tendon lesions. Dahlgren LA Mohammed HO Nixon AJ, J Orthop Res 2005 23 84 92 10.1016/j.orthres.2004.05.007 15607879 (Pubitemid 40045081)
32. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Farndale RW Buttle DJ Barrett AJ, Biochim Biophys Acta 1986 883 173 177 3091074 (Pubitemid 16027978)
33. Fluorometric assay of DNA in cartilage explants using hoechst 33258. Kim YJ Sah RL, Doong JY Grodzinsky AJ, Anal Biochem 1988 174 168 176 10.1016/0003-2697(88)90532-5 2464289 (Pubitemid 18261664)
34. Platelet rich plasma (prp) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. Schnabel LV Mohammed HO Miller BJ Mcdermott WG, Jacobson MS Santangelo KS, Fortier LA, J Orthop Res 2007 25 230 240 10.1002/jor.20278 17106885 (Pubitemid 46344249)
35. Lesions of the deep digital flexor tendon in the digit: a correlative mri and post mortem study in control and lame horses. Blunden A Murray R Dyson S, Equine Vet J 2009 41 25 33 10.2746/042516408X343028 19301578
36. Custom fluorescent-nucleotide synthesis as an alternative method for nucleic acid labeling. Henegariu O Bray-Ward P Ward DD, Nat Biotechnol 2000 18 345 348 10.1038/73815 10700155 (Pubitemid 30159491)
37. Tendon pathology in long-standing achillodynia. Biopsy findings in 40 patients. Movin T Gad A, Reinholt FP Rolf C, Acta Orthop Scand 1997 68 170 175 10.3109/17453679709004002 9174456 (Pubitemid 27202080)
38. Movin and bonar scores assess the same characteristics of tendon histology. Maffulli N Longo UG Franceschi F Rabitti C, Denaro V, Clin Orthop Relat Res 2008 466 1605 1611 10.1007/s11999-008-0261-0 18437501
39. Abnormal tenocyte morphology is more prevalent than collagen disruption in asymptomatic athletes' patellar tendons. Cook JL Feller JA, Bonar SF Khan KM, J Orthop Res 2004 22 334 338 10.1016/j.orthres.2003.08.005 15013093 (Pubitemid 38155289)
40. Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn? Smith RK Webbon PM, Br J Sports Med 2005 39 582 584 10.1136/bjsm.2005.015834 16118291 (Pubitemid 41265299)
41. Restoration of strength despite low stress and abnormal imaging after achilles injury. Trudel G Doherty GP Koike Y Ramachandran N, Lecompte M Dinh L, Uhthoff HK, Med Sci Sports Exerc 2009 41 2009 2016 10.1249/MSS.0b013e3181a706f0 19812517
42. Magnetic resonance signal, rather than tendon volume, correlates to pain and functional impairment in chronic achilles tendinopathy. Gardin A Bruno J Movin T Kristoffersen-Wiberg M, Shalabi A, Acta Radiol 2006 47 718 724 10.1080/02841850600774035 16950711 (Pubitemid 44358965)
43. Development and use of an animal model for investigations on rotator cuff disease. Soslowsky LJ Carpenter JE Debano CM Banerji I, Moalli MR, J Shoulder Elbow Surg 1996 5 383 392 10.1016/S1058-2746(96)80070-X 8933461
44. Studies on the pathogenesis of equine tendonitis following collagenase injury. Williams IF Mccullagh KG, Goodship AE Silver IA, Res Vet Sci 1984 36 326 338 6087432
45. Animal models of tendinopathy. Lake SP Ansorge HL Soslowsky LJ, Disabil Rehabil 2008 30 1530 1541 10.1080/09638280701785460 18608372
46. Stem cell therapy for joint problems using the horse as a clinically relevant animal model. Koch TG Betts DH, Expert Opin Biol Ther 2007 7 1621 1626 10.1517/14712598.7.11.1621 17961087 (Pubitemid 350157491)
47. Tenocytes from ruptured and tendinopathic achilles tendons produce greater quantities of type iii collagen than tenocytes from normal achilles tendons. An in vitro model of human tendon healing. Maffulli N Ewen SW Waterston SW Reaper J, Barrass V, Am J Sports Med 2000 28 499 505 10921640
48. Cloning and expression of type iii collagen in normal and injured tendons of horses. Dahlgren LA Brower-Toland BD Nixon AJ, Am J Vet Res 2005 66 266 270 10.2460/ajvr.2005.66.266 15757126 (Pubitemid 40340302)
49. Evaluation of gene expression through qrt-pcr in cyclically loaded tendons: an in vivo model. Asundi KR King KB Rempel DM, Eur J Appl Physiol 2008 102 265 270 10.1007/s00421-007-0582-9 17922137 (Pubitemid 350245949)
50. Human mesenchymal stem cells modulate allogeneic immune cell responses. Aggarwal S Pittenger MF, Blood 2005 105 1815 1822 10.1182/blood-2004-04-1559 15494428
51. Clinical study of fetal mesencephalic intracerebral transplants for the treatment of parkinson's disease. Kopyov OV Jacques D Lieberman A Duma CM, Rogers RL, Cell Transplant 1996 5 327 337 10.1016/0963-6897(95)02035-7 8689043 (Pubitemid 26096192)
52. Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosis. Religa P Bojakowski K, Bojakowska M Gaciong Z, Thyberg J Hedin U, Cardiovasc Res 2005 65 535 545 10.1016/j.cardiores.2004.10.011 15639493 (Pubitemid 40082495)
53. Why do some females reject males? The molecular basis for male-specific graft rejection. Scott DM Ehrmann IE Ellis PS Chandler PR, Simpson E, J Mol Med 1997 75 103 114 10.1007/s001090050095 9083928 (Pubitemid 27119490)
54. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study. Guest DJ Smith MR, Allen WR, Equine Vet J 2008 40 178 181 10.2746/042516408X276942 18267891 (Pubitemid 351717168)